NCT02877628View on ClinicalTrials.gov

Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

CompletedOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 29, 2018

Study Completion Date

December 31, 2018

Conditions

Liver Transplantation

Interventions

OTHER

Pharmacokinetic-pharmacodynamic model in liver transplantation

Biological: tacrolimus and calcineurin dosage, donor and recipient CYP3A5 and ABCB1 genotypes determination

Trial Locations (1)

35033

CHU de Rennes, Rennes

All Listed Sponsors

lead

Rennes University Hospital

OTHER

NCT02877628 - Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation | Biotech Hunter | Biotech Hunter